Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Callaghan Grant accelerates Cxbladder development

Callaghan Innovation Growth Grant accelerates Cxbladder development

Pacific Edge is delighted to have the support of Callaghan Innovation to further accelerate the development of its molecular cancer detection technology.

Callaghan Innovation has announced a Growth Grant for Pacific Edge that will provide up to $4.5 million spread over three years with additional funding for a further two years available on review.

Pacific Edge Chief Operations Officer Jimmy Suttie says the Government’s Callaghan Innovation fund recognises the ability of the Company to turn scientific discovery into products that bring real benefits for clinicians and patients.

“This funding will provide additional resources to accelerate the development of a range of cancer detection tests, including further non-invasive bladder cancer tests under the brand of Cxbladder.

Cxbladderdetect is now available to patients and their clinicians in the USA, New Zealand and Australia.

This one-stop shop of products is designed to enhance the clinician’s perspective of the urological tract for patients presenting with symptoms of possible bladder cancer.” Pacific Edge’s Chief Executive Officer David Darling says the Callaghan Innovation Growth Grant is also recognition for those shareholders who have supported Pacific Edge through the years of research, product development and commercialisation.

“Pacific Edge started out with a mission to make a real difference by finding ways to identify a range of cancers in their early stages when they can be treated with less devastating impact on peoples lives.” Cxbladder is the first commercial result of that research. Pacific Edge also has patents for diagnostic and prognostic tests for a range of other cancers including colorectal, gastric and melanoma.

The Growth Grant will supplement Pacific Edge’s own research and product development budget and lead to the employment of further research staff at its Dunedin Headquarters and Research Facility.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news